[Behavior of lipoproteins in xanthomatoses].
D002994:Clofibrate / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000209:etiology; D004035:Diet Therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008074:Lipoproteins / Q000378:metabolism*; D009765:Obesity / Q000209:etiology; D012877:Skin Manifestations; D014973:Xanthomatosis / Q000145:classification* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy
D007004:Hypoglycemic Agents; D008074:Lipoproteins; D002994:Clofibrate
Das Verhalten der Lipoproteine bei den Xanthomatosen.